Multiple Myeloma Clinical Trials

A listing of 185 Multiple Myeloma clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Multiple Myeloma

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 185 active clinical trials seeking participants for Multiple Myeloma research studies. The states with the highest number of trials for Multiple Myeloma participants are California, New York, Ohio and Texas.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Study

Recruiting

Are you tired of living with chronic cough? The ASPIRE Study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough. You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you.

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Allergic Asthma

Learn More

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

NCT01408225

Recruiting

The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have created a database of patient information, blood samples, and bone marrow tissue in order to achieve the following three goals: * Surveillance: The investigators want to track what treatments patients get or don't get, how effective they are, how they feel, what complications they suffer, how long they stay in remission, and how long they li... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/27/2025

Locations: Ohio State University Medical Center, Columbus, Ohio

Conditions: Plasma Cell Dyscrasias, Monoclonal Gammopathy of Undetermined Significance, AL Amyloidosis, Multiple Myeloma

Learn More ›

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

NCT06087653

Recruiting

Primary Objective • Assess the safety and tolerability of low-dose lenalidomide administered by continuous subcutaneous (SC) infusion (STAR-LLD) in combination with dexamethasone and a proteasome inhibitor (PI). Secondary Objectives * To assess the immunologic activity of natural killer (NK) cells and T cells for innate and humoral immunity. * To establish the pharmacokinetic (PK) profile of STAR-LLD at a defined infusion rate targeting steady-state blood concentrations. * To determine pharma... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/11/2023

Locations: Gabrail Cancer & Research Center, Canton, Ohio

Conditions: Multiple Myeloma

Learn More ›

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma

NCT06106945

Recruiting

This is a Phase I/II, modular, open-label, multicenter, dose escalation, and dose expansion/optimization study to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary efficacy of AZD0305 in participants with RRMM.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/15/2025

Locations: Research Site, Duarte, California +32 locations

Research Site, Duarte, California

Research Site, Irvine, California

Research Site, Atlanta, Georgia

Research Site, Boston, Massachusetts

Research Site, Ann Arbor, Michigan

Research Site, Saint Louis, Missouri

Research Site, New York, New York

Research Site, Philadelphia, Pennsylvania

Research Site, Fairfax, Virginia

Research Site, Melbourne, Not set

Research Site, Nedlands, Not set

Research Site, Hamilton, Ontario

Research Site, Ottawa, Ontario

Research Site, Montreal, Quebec

Research Site, Beijing, Not set

Research Site, Changsha, Not set

Research Site, Guangzhou, Not set

Research Site, Shenyang, Not set

Research Site, Lille, Not set

Research Site, Nantes, Not set

Research Site, Essen, Not set

Research Site, Freiburg, Not set

Research Site, Hamburg, Not set

Research Site, Lübeck, Not set

Research Site, Nürnberg, Not set

Research Site, Wuerzburg, Not set

Research Site, Kashiwa, Not set

Research Site, Nagoya-shi, Not set

Research Site, Yamagata-shi, Not set

Research Site, Madrid, Not set

Research Site, Pamplona, Not set

Research Site, Salamanca, Not set

Conditions: Multiple Myeloma

Learn More ›

Collection of Tissue Samples for Cancer Research

NCT00900198

Recruiting

Background: -Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection of tissue specimens. Objectives: * To obtain samples from adult and pediatric patients for research purposes from tests and procedures that are done as required by the primary research protocol(s) to which a patient is enrolled or as part of their standard-of-care treatment. * To obtain samples for research purposes from non-surgical procedures, such as percutaneous biopsies, performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Eligibility: -Adult patients (18 years of age and older) and pediatric patients (younger than 18 years of age) who are being evaluated for and/or treated for cancer at the NIH Clinical Center participating sites. Design: * This is a multicenter tissue procurement protocol with NCI as the coordinating center. * For adult patients: specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols to which a patient is enrolled or as part of their standard-of-care treatment. Non-surgical procedures, such as percutaneous biopsies, may also be performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), circulating tumor cells, hair follicles, and bone marrow. These specimens will be stored with unique identifiers and used to perform only those research studies that are outlined in this protocol. * For pediatric patients: tumor biopsy/resection tissue used for pediatric preclinical model development will only be from tissue already being obtained as part of a procedure necessary for the patient s clinical care or as part of a primary research protocol; blood specimens will be collected as part of a blood collection already scheduled for the patient s clinical care or as part of the planned pre-procedure bloodwork; volumes collected will not exceed institutional research limits. * Given the risks associated with any invasive procedure, such as tumor biopsy, the procedure will be discussed in detail with the patients and their parents/guardian (as indicated), including the side effects, prior to obtaining a separate consent for each procedure. A separate consent will not be signed prior to obtaining samples by minimally invasive measures, such as venipuncture. * This study has two separate consent forms at the NIH Clinical Center: one for adult patients to donate specimens for ongoing research on assay development and studies of molecular pathways, and one for adult and age-appropriate pediatric patients to donate samples for the generation of preclinical models. The study also has consent form templates for adult and pediatric patients at participating sites to donate specimens to create preclinical models. * Patients may remain on study for the duration of their consent or completion of the planned procedure, whichever comes first. Read Less

Gender:

ALL

Ages:

2 months and above

Trial Updated:

04/15/2025

Locations: UC Davis, Sacramento, California +16 locations

Conditions: Neoplasms, Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome

Learn More ›

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

NCT05231629

Recruiting

This research study will determine the proportion of patients with lowest minimal residual disease (MRD) response obtainable after receiving 6 cycles of study treatment. Minimal residual disease is multiple myeloma cells below the level of 1 cancer cell out of 100,000 in the bone marrow. For patients who become MRD "negative" (i.e. less than 1 cancer cell out of 100,000) at the end of 6 cycles of therapy, this study will study if that good response can be maintained with 3 additional cycles of... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +8 locations

Conditions: Multiple Myeloma

Learn More ›

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

NCT05243797

Recruiting

This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclistamab in combination with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy after autologous stem cell transplant.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: The University of Arizona Cancer Center, Phoenix, Arizona +209 locations

The University of Arizona Cancer Center, Phoenix, Arizona

University of California-Davis Cancer Center, Sacramento, California

University of California, San Diego (UCSD) Medical Center, San Diego, California

University of Colorado Hospital, Aurora, Colorado

Colorado Blood Cancer Institute, Denver, Colorado

Yale New Haven Hospital, New Haven, Connecticut

Christiana Care, Newark, Delaware

Blood & Marrow Transplant Center, Florida Hospital Medical Group, Orlando, Florida

Moffitt at Memorial Healthcare System, Tampa, Florida

University of Illinois Medical Center at Chicago, Chicago, Illinois

Greenebaum Cancer Center UM of MD, Baltimore, Maryland

John Hopkins, Baltimore, Maryland

Tufts Medical Center, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Karmanos Cancer Institute, Detroit, Michigan

Montefiore Medical Cente, Bronx, New York

Mount Sinai Medical Center - 2, New York, New York

Levine Cancer Institute, Charlotte, North Carolina

Duke University, Durham, North Carolina

East Carolina University, Greenville, North Carolina

Wake Forest Baptist Health, Winston-Salem, North Carolina

University of Cincinnati, Cincinnati, Ohio

Oncology Hematology Care Clinical Trials, Cincinnati, Ohio

Seidman Cancer Center-University Hospitals Cleveland Medical Center, Cleveland, Ohio

Ohio State Medical Center, James Cancer Center, Columbus, Ohio

Lehigh Valley Health Network, Allentown, Pennsylvania

Penn State Hershey Medical Center, Hershey, Pennsylvania

Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Medical University of South Carolina (MUSC), Charleston, South Carolina

Gibbs Cancer Center, Spartanburg, South Carolina

Vanderbilt University, Nashville, Tennessee

Renovatio Clinical Research, El Paso, Texas

Baylor College of Medicine Center for Cell and Gene Therapy, Houston, Texas

Renovatio Clinical Research, The Woodlands, Texas

LDS Hospital/ Intermountain Healthcare, Salt Lake City, Utah

Virginia Oncology Associates, Norfolk, Virginia

St Vincent HSHS (Green Bay Oncology), Green Bay, Wisconsin

University of Wisconsin Hospital and Clinics, Madison, Wisconsin

Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin

Sunshine Coast Health, Birtinya, Queensland

Flinders Medical Centre, Adelaide, Not set

Townsville University Hospital, Douglas, Not set

Barwon Health University Hospital Geelong Andrew Love Cancer Centre, Geelong, Not set

Alfred Hospital, Melbourne, Not set

Austin Health, Melbourne, Not set

Calvary Mater Hospital, Newcastle, Not set

Sunshine Coast Health, Sunshine Coast, Not set

Concord Repatriation General Hospital, Sydney, Not set

Royal North Shore Hospital, Sydney, Not set

Landeskrankenhaus, Feldkirch, Feldkirch, Not set

Medizinische Universitaet Innsbruck, Innsbruck, Not set

University Hospital Krems/Donau, Krems, Not set

Kepler Universitätsklinikum Med Campus III, Linz, Not set

Ordensklinikum Linz GmbH, Linz, Not set

Uniklinikum Salzburg, Salzburg, Not set

Clinic Ottakring, Vienna, Not set

LKH Hochsteiermark, Vienna, Not set

Medical University Of Vienna, Vienna, Not set

Jessa Ziekenhuis, Hasselt, Not set

Department of Hematology, CH Jolimont, La Louvière, Not set

Algemeen Ziekenhuis Delta, Leuven, Not set

University Hospital Leuven, Leuven, Not set

Centre hospitalier universitaire de Liege, Liège, Not set

Hospital Mãe de Deus - Centro Integrado de Oncologia, Porto Alegre, Not set

Hospital Santa Rita, Porto Alegre, Not set

Instituto Americas de Ensino,Pesquisa e Inovação, Rio de Janeiro, Not set

IDOR- Instituto D'or de pesquisa. Av. São Rafael, Salvador, Not set

A Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, Not set

Clínica Medica São Germano,Grupo Oncoclínicas Pesquisa Clínica, São Paulo, Not set

Departamento de Oncologia Clínica AC Camargo Cancer Center, São Paulo, Not set

Grupo Oncoclínicas Pesquisa Clínica, São Paulo, Not set

Hemocentro UNICAMP, Universidade Estadual de Campinas, São Paulo, Not set

Hospital das Clínicas da Universidade de São Paulo, São Paulo, Not set

Hospital Paulistano, Centro de Pesquisa Clinica R. Martiniano de Carvalho, São Paulo, Not set

Onco Star, São Paulo, Not set

Universidade Federal de São Paulo - Hospital São Paulo, São Paulo, Not set

Cross Cancer Institute, Edmonton, Not set

QEII Health Sciences Centre, Halifax, Not set

The Ottawa General Hospital, Ottawa, Not set

Saskatoon Cancer Center, Saskatoon, Not set

"Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS)", Sherbrooke, Not set

Princess Margaret Cancer Centre, Toronto, Not set

BC Cancer, Vancouver, Not set

Beijing Chaoyang Hospital, Beijing, Not set

Peking University First Hospital, Beijing, Not set

North China University of Science and Technology Affiliated Hospital.Hematology Department, Hebei, Not set

Henan Cancer Hospital, Henan, Not set

Shandong Qilu Hospital, Shandong, Not set

Shanghai Fourth People's Hospital, Shanghai, Not set

Shenyang City, Liaoning Province, Hematology department, Shenyang, Not set

Shenzhen Second People's Hospital, Shenzhen, Not set

Institute of Hematology & Blood Disease Hospital Chinese Academy of Medical Science, Tianjin, Not set

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set

Tongji Hospital, Tongji Medical College of Hust, Wuhan, Not set

The First Affiliated Hospital, Zhejiang University College of Medicine, Zhejiang, Not set

Fakultni Nemocnice Hradec Kralove, Hradec Králové, Not set

University Hospital Olomouc, Olomouc, Not set

Fakultni Nemocnice Ostrava, Ostrava, Not set

Fakultni Nemocnice Plzen, Plzen, Not set

Vseobecna Fakultni Nemocnice V Praze, Praha, Not set

Aarhus Universitetshospital, Aarhus, Not set

Rigshospitalet, Copenhagen, Not set

Odense University Hospital, Odense, Not set

Lillebaelt Hospital, Vejle, Not set

Centre Hospitalier Universitaire De Bordeaux, Bordeaux, Not set

Department of Hematology, CHU Lille, Lille, Not set

Institut Paoli Calmettes, Marseille, Not set

Centre Hospitalier Universitaire De Montpellier, Montpellier, Not set

Centre Hospitalier Universitaire De Nantes, Nantes, Not set

Hopital Saint Louis, Paris, Not set

Hôpital Saint-Antoine, Paris, Not set

Centre Hospitalier Universitaire De Poitiers, Poitiers, Not set

Centre Hospitalier Universitaire De Toulouse, Toulouse, Not set

University Medical Center Hamburg-Eppendorf, Hamburg, Not set

Universitaetsklinikum Heidelberg AöR, Heidelberg, Not set

Universitaetsklinikum Jena KöR, Jena, Not set

Universitaetsklinikum Schleswig-Holstein AöR, Lübeck, Not set

Klinikum rechts der Isar der TU Muenchen AöR, München, Not set

Klinikum Nuernberg, Nürnberg, Not set

Universitaetsklinikum Tuebingen AöR, Tübingen, Not set

University Hospital of Würzburg, Würzburg, Not set

University General Hospital Of Alexandroupoli, Alexandroupolis, Not set

Evaggelismos Hospital, Athens, Not set

Regional General Hospital Alexandra, Athens, Not set

Theageneio Cancer Hospital, Thessaloníki, Not set

Cork University Hospital, Cork, Not set

Beaumont Hospital, Dublin, Not set

St James's Hospital, Dublin, Not set

St Vincent's University Hospital, Dublin, Not set

University Hospital Galway, Galway, Not set

University Hospital Limerick, Limerick, Not set

The Barzilai Medical Center, Be'er Sheva, Not set

Health Care Campus, Haifa, Not set

Hadassah Medical Center, Jerusalem, Not set

Beilinson Hospital, Petah tikva, Not set

Chaim Sheba Medical Center, Ramat Gan, Not set

Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set

Azienda Sanitaria Locale Al Di Alessandria, Alessandria, Not set

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi, Ancona, Not set

AOU G. Baccelli, Bari, Not set

Policlinico di Bari, Bari, Not set

A.O. Papa Giovanni XXIII, Bergamo, Not set

A.O.U. di Bologna - Policlinico S. Orsola Malpighi, Bologna, Not set

A.O.Spedali Civili di Brescia, Brescia, Not set

Ospedale Oncologico 'A. Businco', Cagliari, Not set

Azienda Ospedaliera-Universitaria Di Cosenza, Cosenza, Not set

Careggi University Hospital, Firenze, Not set

IRCCS Ospedale Policlinico San Martino, Genova, Not set

IRCCS Ospedale Maggiore Policlinico, Milano, Not set

Azienda Ospedaliero Universitaria Di Modena, Modena, Not set

Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli, Napoli, Not set

UOC Oncoematologia, Ospedale Policlinico Federico II, Napoli, Not set

Azienda Ospedaliero-Universitaria Maggiore Della Carita, Novara, Not set

UOC Ematologia - Azienda Ospedale - Università Padova Ospedale Giustinianeo, Padova, Not set

Department of Hematology and Bone Marrow Transplant Centre, Azienda Ospedaliero - Universitaria di Parma, Parma, Not set

Fondazione IRCCS Policlinico San Matteo, Pavia, Not set

Azienda Sanitaria Locale Di Pescara, Pescara, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Azienda USL IRCCS Di Reggio Emilia, Reggio, Not set

Ospedale "Infermi" di Rimini, Rimini, Not set

Ematologia, Azienda Policlinico Umberto I, Roma, Not set

Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Not set

A.O.U. Città della Salute e della Scienza di Torino - SC Ematologia U, Torino, Not set

Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Not set

Azienda Sanitaria Universitaria Friuli Centrale, Udine, Not set

Chonnam National University Hwasun Hospital, Gwangju, Not set

Department of Oncology, Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Hospital, Internal Medicine, Seoul, Not set

Severance Hospital, Seoul, Not set

St. Mary's Hospital, Seoul, Not set

Noordwest Ziekenhuisgroep Stichting, Alkmaar, Not set

Amsterdam University Medical Center, Amsterdam, Not set

Albert Schweitzer Ziekenhuis, Dordrecht, Not set

Maxima Medisch Centrum, Eindhoven, Not set

University Medical Center Groningen, Groningen, Not set

Dijklander Ziekenhuis, Hoorn, Not set

St. Antonius Ziekenhuis, Nieuwegein, Not set

Erasmus University Medical Center Rotterdam, Rotterdam, Not set

Maasstad Ziekenhuis, Rotterdam, Not set

Oslo University Hospital, Oslo, Not set

St. Olavs hospital HF, Trondheim, Not set

Department of Hematology and Transplantology University Clinical Center, Gdańsk, Not set

SPZOZ MSWiA w Poznaniu im. Prof. Ludwika Bierkowskiego, Poznań, Poznań, Not set

Uniwersytecki Szpital Kliniczny, Wrocław, Not set

CCAB Centro Clinico Academico Braga Associacao, Braga, Not set

Champalimaud Clinical Centre, Lisboa, Not set

Instituto Portugues De Oncologia De Lisboa Francisco Gentil E.P.E., Lisboa, Not set

Instituto Portugues De Oncologia Do Porto Francisco Gentil E.P.E., Porto, Not set

Sao Joao University Hospital Center, Porto, Not set

Unidade Local De Saude De Gaia/Espinho E.P.E., Porto, Not set

Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E., Vila Real, Not set

University Clinical Center of Serbia, Belgrade, Not set

Clinical Centre of Kragujevac, Kragujevac, Not set

Clinical Centre of Nis, Niš, Not set

Clinical Centre of Vojvodina, Novi Sad, Not set

University Hospital Basel, Basel, Not set

Inselspital, Bern, Not set

Kantonsspital St. Gallen, Saint Gallen, Not set

Ankara Liv Hospital, Ankara, Not set

Ankara University Hospital, Ankara, Not set

Florence Nightingale Hospital, Istanbul, Not set

Medipol Mega University Hospital, Istanbul, Not set

Ege University Medical faculty Hospital Internal Medicine Department Adult Hematology Unit, İzmir, Not set

Izmir Economy University, Medical Point Hospital, İzmir, Not set

Erciyes University Hospital, Kayseri, Not set

Hammersmith Hospital - Imperial College NHS Healthcare Trust, London, Not set

University College London (UCL), London, Not set

The Royal Marsden Hospital, Sutton, Not set

Conditions: Multiple Myeloma

Learn More ›

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

NCT06215118

Recruiting

The main purpose of the study is to understand how safe and tolerable is elranatamab when given along with iberdomide. There are 2 parts to this study. Part 1 will look at how safe and tolerable is elranatamab when given with iberdomide. Part 2 will look at the correct amount of this combination that can be given to patients with relapsed or refractory multiple myeloma. Myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies). Refractory means a disea... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: Emory University Hospital Midtown, Atlanta, Georgia +29 locations

Emory University Hospital Midtown, Atlanta, Georgia

Emory University Hospital, Atlanta, Georgia

Winship Cancer Institute, Atlanta, Georgia

Indiana CTSI Clinical Research Center (ICRC), Indianapolis, Indiana

Indiana University Health University Hospital, Indianapolis, Indiana

Indiana University Melvin and Bren Simon Comprehensive Cancer Center (IUSCCC), Indianapolis, Indiana

University of Maryland, Baltimore, Maryland

University of Massachusetts Chan Medical School, Worcester, Massachusetts

Methodist Hospital, Omaha, Nebraska

Oncology Hematology West P.C. dba Nebraska Cancer - Methodist, Omaha, Nebraska

Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

MSK Basking Ridge, Basking Ridge, New Jersey

MSK Monmouth, Middletown, New Jersey

MSK Bergen, Montvale, New Jersey

MSK Commack, Commack, New York

MSK Westchester, Harrison, New York

Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City, New York

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York, New York

Memorial Sloan Kettering Cancer Center - Main Campus, New York, New York

MSK Nassau, Uniondale, New York

Fred Hutchinson Cancer Center, Seattle, Washington

University of Washington, Seattle, Washington

Townsville University Hospital, Douglas, Queensland

Epworth Freemasons, East Melbourne, Victoria

Epworth Hospital, Richmond, Victoria

Slade Pharmacy, Richmond, Victoria

Dr. Everett Chalmers Regional Hospital, Fredericton, New Brunswick

CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal, Quebec

Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer, Sherbrooke, Quebec

Conditions: Multiple Myeloma

Learn More ›

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

NCT06152575

Recruiting

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer). This study is seeking participants who: * Are 18 years of age or older and have MM. * Have received treatments before for MM. * Have MM that has returned or not responded to their most recent treatment. Half of the participants will receive elranatamab. The other half of participants will receive a combination t... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: Infirmary Cancer Care, Mobile, Alabama +162 locations

Infirmary Cancer Care, Mobile, Alabama

Beverly Hills Cancer Center, Beverly Hills, California

Community Cancer Institute, Clovis, California

University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento, California

University of California, Sacramento, California

UCHealth Harmony, Fort Collins, Colorado

Longs Peak Hospital, Longmont, Colorado

Miami Cancer Institute at Baptist Health, Inc., Miami, Florida

BRCR Global, Plantation, Florida

BRCR Medical Center Inc, Plantation, Florida

BRCR Global - Tamarac, Tamarac, Florida

Community Health Network, Inc., Indianapolis, Indiana

Bryan Medical Center, Lincoln, Nebraska

NHO Revive Research Institute, LLC, Lincoln, Nebraska

Atlantic Health System Morristown Medical Center, Morristown, New Jersey

WMCHealth Advanced Physician Services, Hawthorne, New York

Cayuga Cancer Center at Cayuga Park, Ithaca, New York

Cayuga Medical Center, Ithaca, New York

Westchester Medical Center, Valhalla, New York

Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio

TriHealth Cancer Institute-Good Samaritan Hospital, Cincinnati, Ohio

Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio

The Jewish Hospital, Cincinnati, Ohio

Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio

Cleveland Clinic, Cleveland, Ohio

St Francis Cancer Center, Greenville, South Carolina

Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy, Dallas, Texas

Baylor University Medical Center, Dallas, Texas

Houston Methodist Hospital, Houston, Texas

Houston Methodist Willowbrook Hospital, Houston, Texas

US Oncology Investigational Products Center (IPC), Irving, Texas

Houston Methodist Sugar Land Hospital, Sugar Land, Texas

Baylor Scott & White Medical Center - Temple, Temple, Texas

WVU Cancer Institute, Morgantown, West Virginia

University of Wisconsin Clinical Science Center, Madison, Wisconsin

Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires

Hospital Universitario Austral, Pilar, Buenos Aires

Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Ciudad Autónoma DE Buenos Aires

Hospital Italiano de La Plata, La Plata, Not set

UZ Brussel, Brussels, Bruxelles-capitale, Région DE

Grand Hôpital de Charleroi, Gilly, Hainaut

Epicura, Hornu, Hainaut

CHR Verviers - La Tourelle, Verviers, Liège

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi, Yvoir, Namur

UZ Gent, Gent, Oost-vlaanderen

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, RIO Grande DO SUL

Centro de Pesquisa Clínica - Área Administrativa, Porto Alegre, RIO Grande DO SUL

Hospital Mae de Deus, Porto Alegre, RIO Grande DO SUL

Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, SÃO Paulo

Clínica Médica São Germano LTDA, SP, SÃO Paulo

Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Not set

Americas Centro de Oncologia Integrado, Rio de Janeiro, Not set

Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Not set

ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis, São Paulo, Not set

Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set

Hospital do Coracao, São Paulo, Not set

HU UNIFESP / SPDM - Hospital São Paulo, São Paulo, Not set

Universidade Federal de Sao Paulo, São Paulo, Not set

Clínica Médica São Germano S/S Ltda, São Paulo, Not set

The Moncton Hospital, Moncton, New Brunswick

Jewish General Hospital, Montreal, Quebec

Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎ, Montreal, Quebec

Fakultní nemocnice Brno Bohunice, Brno, Brno-město

Fakultni nemocnice Olomouc, Olomouc, Olomoucký KRAJ

Fakultni nemocnice Kralovske Vinohrady, Prague, Praha 10

Vseobecna fakultni nemocnice v Praze, Praha 2, Not set

Rigshospitalet, Copenhagen, Hovedstaden

Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland

Aalborg Universitetshospital, Syd, Aalborg, Nordjylland

Tampereen yliopistollinen sairaala, Tampere, Pirkanmaa

Oulun yliopistollinen sairaala, Oulu, Pohjois-pohjanmaa

Kuopion Yliopistollinen Sairaala, Kuopio, Pohjois-savo

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa

Turku University Hospital, Turku, Varsinais-suomi

CHU Bordeaux Haut-Leveque, Pessac, Aquitaine

Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Lorraine

Centre Hospitalier de Dunkerque, Dunkirk, Nord-pas-de-calais

Hôpital NOVO, Cergy Pontoise, Val-d'oise

Hôpital NOVO, Pontoise, Val-d'oise

Henri Mondor Hospital, Créteil, Val-de-marne

CHD Vendee, La Roche-sur-Yon, Vendée

Centre Hospitalier de la Côte Basque, Bayonne, Not set

Centre Hospitalier du Mans, Le Mans, Not set

Hôpital Universitaire Necker Enfants Malades, Paris, Not set

Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set

Centre Hospitalier de Cornouaille, Quimper, Not set

Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau, Tours, Not set

Universitaetsklinikum Freiburg, Freiburg, Baden-württemberg

Universitaetsklinikum Ulm, Ulm, Baden-württemberg

Universitätsklinikum Jena, Jena, Thüringen

Vivantes Klinikum Am Urban, Berlin, Not set

Medizinische Universität Lausitz - Carl Thiem, Cottbus, Not set

Asklepios Altona, Hamburg, Not set

St. Barbara-Klinik Hamm-Heessen, Hamm, Not set

Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Not set

University Hospital of Alexandroupolis, Alexandroupolis, Anatolikí Makedonía KAI Thráki

Evangelismos General Hospital of Athens, Athens, Attikí

Alexandra General Hospital of Athens, Athens, Attikí

"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía

University Hospital of Ioannina, Ioannina, Ípeiros

Rabin Medical Center, Petah-Tikva, Hamerkaz

Sheba Medical Center, Ramat Gan, Hamerkaz

Sourasky Medical Center, Tel Aviv, Tell Abīb

Hadassah Medical Center, Jerusalem, Yerushalayim

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-romagna

P.O. San Carlo Borromeo- ASST SANTI PAOLO E CARLO, Milano, Lombardia

Azienda Ospedaliero Universitaria delle Marche, Ancona, Marche

A.O.U. Policlinico Paolo Giaccone, Palermo, Sicilia

Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Istituto Europeo di Oncologia IRCCS, Milano, Not set

Ospedale Civile dello Spirito Santo, Pescara, Not set

Nagoya City University Hospital, Nagoya, Aichi

Toyohashi Municipal Hospital, Toyohashi, Aichi

Ehime Prefectural Central Hospital, Matsuyama, Ehime

Gunma University Hospital, Maebashi, Gunma

National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma

Kobe City Medical Center General Hospital, Kobe, Hyogo

Iwate Medical University Hospital, Shiwa-gun Yahaba-cho, Iwate

Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka

Nippon Medical School Hospital, Bunkyo-ku, Tokyo

Japanese Foundation for Cancer Research, Koto, Tokyo

Yamanashi Prefectural Central Hospital, Kofu-shi, Yamanashi

Kagoshima University Hospital, Kagoshima, Not set

University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set

National Hospital Organization Okayama Medical Center, Okayama, Not set

Okayama Rosai Hospital, Okayama, Not set

Yamagata University Hospital, Yamagata, Not set

Maastricht UMC+, Maastricht, Limburg

Albert Schweitzer Ziekenhuis, locatie Dordwijk, Dordrecht, Zuid-holland

Akershus Universitetssykehus, Lørenskog, Akershus

St. Olavs Hospital, Trondheim, Sør-trøndelag

Sykehuset i Vestfold, Tønsberg, Vestfold

Oslo Universitetssykehus Ullevål, Oslo, Not set

Institut Català d'Oncologia (ICO) - Badalona, Badalona, Barcelona [barcelona]

Cetir-Ascires, Barcelona, Barcelona [barcelona]

Hospital Universitari Mutua Terrassa, Terrassa, Barcelona [barcelona]

Hospital Clínic de Barcelona, Barcelona, Catalunya [cataluña]

Hospital General Universitario Morales Meseguer, Murcia, Galicia [galicia]

Institut Català d'Oncologia (ICO) - Girona, Girona, Girona [gerona]

Hospital Universitario Infanta Leonor, Madrid, Madrid, Comunidad DE

ASCIRES ECG Médica S.L, València, Valenciana, Comunitat

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Hospital Universitario HM Sanchinarro, Madrid, Not set

H.R.U Málaga - Hospital General, Málaga, Not set

Centro de Diagnóstico y Resonancia Magnética, Salamanca, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Universitari i Politecnic La Fe, València, Not set

Falu Lasarett, Falun, Not set

Universitetssjukhuset Örebro, Örebro, Örebro LÄN [se-18]

Queen Elizabeth Hospital Birmingham, Birmingham, England

Maidstone Hospital, Maidstone, Kent

St Bartholomew's Hospital, London, London, CITY OF

Hammersmith Hospital, London, London, CITY OF

Churchill Hospital, Oxford, Oxfordshire

Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire

Royal Marsden Hospital (Sutton), London, Sutton

Kent and Canterbury Hospital, Canterbury, Not set

New Cross Hospital, Wolverhampton, Not set

Conditions: Multiple Myeloma

Learn More ›

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06223516

Recruiting

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come back (relapsed) or may not get better (refractory) with treatment. This is a study to determine the safety and pharmacokinetics of ABBV-383 in adult participants with relapsed/refractory (R/R) MM. ABBV-383 is an i... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: Mayo Clinic Arizona /ID# 260799, Phoenix, Arizona +14 locations

Conditions: Multiple Myeloma

Learn More ›

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

NCT05090566

Recruiting

The purpose of this study is to determine the Recommended Phase 2 Dose and clinical benefit of elranatamab in combination with other anti-cancer therapies in participants with multiple myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: Banner Gateway Medical Center, Gilbert, Arizona +28 locations

Banner Gateway Medical Center, Gilbert, Arizona

Banner Gateway Medical Pavilion, Gilbert, Arizona

Banner MD Anderson Cancer Center, Gilbert, Arizona

University of Arkansas for Medical Sciences - Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas

Beverly Hills Cancer Center, Beverly Hills, California

Clinical Research Advisors, Encino, California

Clinical Research Advisors, Los Angeles, California

Cedars Sinai Medical Center Oncology IDS Pharmacy Attn:Suwicha Limvorasak ,PharmaD, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI), Los Angeles, California

Clinical Research Advisors, Los Angeles, California

Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables, Florida

Sylvester Comprehensive Cancer Center- Deerfield Beach, Deerfield Beach, Florida

Sylvester Comprehensive Cancer Center, Miami, Florida

UHealth Tower, Miami, Florida

UChicago Medicine - River East, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

UChicago Medicine at Ingalls - Flossmoor, Flossmoor, Illinois

UChicago Medicine Ingalls Memorial, Harvey, Illinois

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois

The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park, Illinois

UChicago Medicine at Ingalls - Tinley Park, Tinley Park, Illinois

OIDS, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Also Imaging Facility), Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Multiple Myeloma

Learn More ›

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06158841

Recruiting

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come back (relapsed) or may not get better (refractory) with treatment. This is a study to determine change in disease symptoms of etentamig compared to standard available therapies in adult participants with relapsed/r... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: University of Alabama at Birmingham - Main /ID# 261434, Birmingham, Alabama +133 locations

University of Alabama at Birmingham - Main /ID# 261434, Birmingham, Alabama

Alta Bates Summit Medical Center for Research /ID# 261438, Berkeley, California

Providence - St. Jude Medical Center /ID# 262031, Fullerton, California

Cedars-Sinai Medical Center /ID# 261008, Los Angeles, California

Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 246230, Jacksonville, Florida

Winship Cancer Institute of Emory University /ID# 262525, Atlanta, Georgia

University of Illinois at Chicago /ID# 246349, Chicago, Illinois

Springfield Clinic /ID# 262266, Springfield, Illinois

Center for Cancer and Blood Disorders /ID# 263637, Bethesda, Maryland

Regents of the University of Michigan /ID# 261577, Ann Arbor, Michigan

Karmanos Cancer Institute - Detroit /ID# 266298, Detroit, Michigan

Henry Ford Hospital /ID# 262704, Detroit, Michigan

Barbara Ann Karmanos Cancer Institute - McLaren Greater Lansing /ID# 259891, Lansing, Michigan

University of Missouri Hospital /ID# 261553, Columbia, Missouri

New York Cancer & Blood Specialists - Bay Shore /ID# 261524, Bay Shore, New York

Eastchester Center for Cancer Care /ID# 262952, Bronx, New York

New York Cancer & Blood Specialists - Lake Success Medical Oncology /ID# 262953, New Hyde Park, New York

New York Cancer and Blood Specialists - New York /ID# 262951, New York, New York

University of North Carolina /ID# 259854, Chapel Hill, North Carolina

Levine Cancer Institute /ID# 246199, Charlotte, North Carolina

Duke University Medical Center /ID# 259694, Durham, North Carolina

University Of Cincinnati Medical Center /ID# 246415, Cincinnati, Ohio

Cleveland Clinic Main Campus /ID# 246183, Cleveland, Ohio

Medical University of South Carolina /ID# 259692, Charleston, South Carolina

Virginia Cancer Specialists - Fairfax /ID# 262792, Fairfax, Virginia

VCU Massey Cancer Center: Dalton Oncology Clinic /ID# 261944, Richmond, Virginia

St George Hospital /ID# 261806, Kogarah, New South Wales

Liverpool Hospital /ID# 262159, Liverpool, New South Wales

Calvary Mater Newcastle /ID# 261804, Waratah, New South Wales

Princess Alexandra Hospital /ID# 261810, Woolloongabba, Queensland

Monash Health - Monash Medical Centre /ID# 262158, Clayton, Victoria

St Vincent's Hospital Melbourne /ID# 261808, Fitzroy Melbourne, Victoria

Box Hill Hospital /ID# 262784, Melbourne, Victoria

Universitaetsklinikum Krems /ID# 261509, Krems an der Donau, Niederoesterreich

Ordensklinikum Linz GmbH Elisabethinen /ID# 245609, Linz, Oberoesterreich

Medizinische Universitaet Graz /ID# 261908, Graz, Steiermark

Klinik Ottakring /ID# 245829, Vienna, Wien

Algemeen Ziekenhuis klina /ID# 260856, Brasschaat, Antwerpen

AZ Sint-Jan Brugge /ID# 245345, Brugge, Not set

University Health Network_Princess Margaret Cancer Centre /ID# 261566, Toronto, Ontario

Beijing Chaoyang Hospital,Capital Medical University /ID# 245533, Beijing, Beijing

Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 245545, Beijing, Beijing

Fujian Medical University Union Hospital /ID# 245558, Fuzhou, Fujian

Sun Yat-Sen University Cancer Center /ID# 245542, Guangzhou, Guangdong

People's Hospital of Henan Province /ID# 260918, Zhengzhou, Henan

Henan Cancer Hospital /ID# 245536, Zhengzhou, Henan

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 245549, Wuhan, Hubei

Zhongda Hospital Southeast University /ID# 245563, Nanjing, Jiangsu

The First Affiliated Hospital of Soochow University /ID# 245544, Suzhou, Jiangsu

The First Affiliated Hospital of Nanchang University /ID# 245537, Nanchang, Jiangxi

The First Hospital of China Medical University /ID# 245547, Shenyang, Liaoning

Shanghai Tongji Hospital /ID# 245539, Shanghai, Shanghai

Institute of Hematology and Blood Diseases Hospital /ID# 265702, Tianjin, Tianjin

Tianjin Medical University General Hospital /ID# 260851, Tianjin, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 260883, Hangzhou, Zhejiang

Sir Run Run Shaw Hospital Zhejiang University School of Medicine /ID# 260882, Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University /ID# 245550, Wenzhou, Zhejiang

Fakultní Nemocnice Brno - Jihlavská /ID# 245689, Brno, Brno-mesto

Fakultní nemocnice Hradec Králové - Sokolská /ID# 245690, Hradec Králové, Hradec Kralove

Fakultni Nemocnice Ostrava /ID# 245686, Ostrava, Ostrava-mesto

Vseobecna fakultni nemocnice v Praze /ID# 245691, Praha, Not set

Odense University Hospital /ID# 260924, Odense, Syddanmark

Sygehus Lillebalt, Vejle /ID# 260923, Vejle, Syddanmark

Ch Saint Quentin /Id# 261856, St Quentin CEDEX, Aisne

Centre Hospitalier du Mans /ID# 261852, Le Mans CEDEX 9, Sarthe

CH Henri Duffaut /ID# 261844, Avignon CEDEX 9, Vaucluse

Centre Hospitalier Régional d'Orléans - Hôpital de la Source /ID# 261854, Orléans, Not set

Universitaetsklinikum Freiburg /ID# 262147, Freiburg, Baden-Wuerttemberg

Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 260689, Berlin, Not set

Universitaetsklinikum Hamburg-Eppendorf /ID# 260651, Hamburg, Not set

Alexandra General Hospital /ID# 240591, Athens, Attiki

University General Hospital Attikon /ID# 240592, Athens, Attiki

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 240596, Athens, Not set

General University Hospital of Thessaloniki AXEPA /ID# 240595, Thessaloniki, Not set

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 261648, Gyor, Gyor-Moson-Sopron

Semmelweis Egyetem /ID# 261647, Budapest, Not set

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 261646, Budapest, Not set

The Chaim Sheba Medical Center /ID# 245497, Ramat Gan, Tel-Aviv

Tel Aviv Sourasky Medical Center /ID# 245495, Tel Aviv, Tel-Aviv

Shaare Zedek Medical Center /ID# 245681, Jerusalem, Yerushalayim

Rabin Medical Center /ID# 245498, Petah Tikva, Not set

ASST Ovest Milanese /ID# 256813, Legnano, Milano

Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 256810, Rome, Roma

Azienda Ospedaliero Universitaria delle Marche /ID# 256812, Ancona, Not set

AOU Policlinico G. Rodolico - San Marco /ID# 256814, Catania, Not set

Anjo Kosei Hospital /ID# 263434, Anjo, Aichi

Nagoya City University Hospital /ID# 263320, Nagoya, Aichi

Chiba University Hospital /ID# 262006, Chiba-shi, Chiba

University of Fukui Hospital /ID# 264222, Yoshida-gun, Fukui

Kyushu University Hospital /ID# 264704, Fukuoka-shi, Fukuoka

Gifu Municipal Hospital /ID# 263321, Gifu-shi, Gifu

Gunma University Hospital /ID# 262580, Maebashi-shi, Gunma

Chugoku Central Hospital /ID# 263431, Fukuyama, Hiroshima

Hyogo Prefectural Amagasaki General Medical Center /ID# 265696, Amagasaki, Hyogo

University Hospital Kyoto Prefectural University of Medicine /ID# 262585, Kyoto-shi, Kyoto

Miyagi Cancer Center /ID# 265094, Natori, Miyagi

Naha City Hospital /ID# 263972, Naha, Okinawa

The University of Osaka Hospital /ID# 263974, Suita-shi, Osaka

Saitama Cancer Center /ID# 262586, Kitaadachi-gun, Saitama

Japanese Red Cross Medical Center /ID# 261717, Shibuya-ku, Tokyo

Seoul National University Hospital /ID# 245491, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 245492, Seoul, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 245493, Seoul, Seoul Teugbyeolsi

Ulsan University Hospital /ID# 245490, Ulsan, Ulsan Gwang Yeogsi

Yonsei University Health System Severance Hospital /ID# 245489, Seoul, Not set

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu /ID# 260172, Wroclaw, Dolnoslaskie

Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie /ID# 260168, Lublin, Lubelskie

Uniwersyteckie Centrum Kliniczne /ID# 260169, Gdansk, Pomorskie

Fundacao Champalimaud /ID# 246258, Lisbon, Lisboa

Unidade Local de Saude de Santa Maria, EPE /ID# 246255, Lisboa, Not set

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE /ID# 246257, Porto, Not set

Alberts Cellular Therapy /ID# 245725, Pretoria, Gauteng

Constantiaberg Haematology /ID# 261320, Cape Town, Western Cape

Haemalife Inc. /ID# 245724, Kuilsrivier, Western Cape

Instituto Catalan de Oncologia (ICO) Badalona /ID# 246398, Badalona, Barcelona

Complejo Hospitalario Universitario Ourense /ID# 246400, Orense, Ourense

Hospital de Leon /ID# 261624, Leon, Not set

Hospital General Universitario Gregorio Maranon /ID# 246401, Madrid, Not set

Hospital Universitario de Salamanca /ID# 262218, Salamanca, Not set

Hospital Universitario y Politecnico La Fe /ID# 261625, Valencia, Not set

Helsingborgs Lasarett /ID# 262513, Helsingborg, Skane Lan

Uddevalla sjukhus /ID# 262034, Uddevalla, Vastra Gotalands Lan

Falu Lasarett /ID# 262231, Falun, Not set

National Taiwan University Hospital /ID# 245482, Taipei City, Taipei

China Medical University Hospital /ID# 245483, Taichung, Not set

Taichung Veterans General Hospital /ID# 261142, Taichung, Not set

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 261672, Ankara, Not set

Antalya Egitim Ve Arastirma Hastanesi /ID# 261674, Antalya, Not set

Trakya University Medical Facu /ID# 261673, Edirne, Istanbul, Not set

Istanbul Florence Nightingale Hospital /ID# 271543, Şişli, Not set

Addenbrooke's Hospital /ID# 261104, Cambridge, Cambridgeshire

Guys and St Thomas NHS Foundation Trust /ID# 262488, London, Greater London

Nottingham City Hospital /ID# 261105, Nottingham, Nottinghamshire

The Christie Hospital /ID# 261102, Manchester, Not set

Conditions: Multiple Myeloma

Learn More ›

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

NCT05434689

Recruiting

Similar to the paradigm established in other hematologic malignancies that are considered curable, the achievement of MRD(-) status is necessary for long term disease control in MM. The fact that the majority of patients remain MRD (+) after induction therapy and AHCT points to the opportunity to deploy novel agents with complementary mechanism of action and favorable toxicity profile to reach and maintain MRD (-) status. Given its favorable toxicity profile, the convenience of oral administrat... Read More

Gender:

ALL

Ages:

19 years and above

Trial Updated:

04/14/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +5 locations

Conditions: Multiple Myeloma

Learn More ›